Metamizole (dipyrone)‐induced agranulocytosis: Does the risk vary according to ethnicity?

@article{Shah2019MetamizoleA,
  title={Metamizole (dipyrone)‐induced agranulocytosis: Does the risk vary according to ethnicity?},
  author={Rashmi R Shah},
  journal={Journal of Clinical Pharmacy and Therapeutics},
  year={2019},
  volume={44},
  pages={129 - 133}
}
  • R. Shah
  • Published 11 October 2018
  • Medicine
  • Journal of Clinical Pharmacy and Therapeutics
Based on spontaneous reports from Spain, it is claimed that the British, Irish and Scandinavians are at a greater risk of dipyrone‐induced agranulocytosis. This report examines the evidence. 
Paediatric Agranulocytosis Associated with Metamizole Treatment
TLDR
Considering the availability of alternative options to treat fever and pain, and given the side-effect profile of metamizole, it should not be the preferred, first-line antipyretic treatment in children. Expand
Dipyrone (metamizole), overrated risks?
TLDR
It is highlighted that the most salient negative aspect was that only 17% of the trials included in this paper had a low risk of bias, but in contrast, the strengths of this review included the high sensitivity of the search and the large number of participating patients. Expand
High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis
TLDR
The results do not support an HLA-restricted T cell-mediated immune mechanism for MIA, but an efficient high-resolution (three-field) eight-locus HTS HLA resequencing method was established and demonstrated the feasibility of its application to pharmacogenetic studies. Expand
Drug-Induced Idiosyncratic Agranulocytosis - Infrequent but Dangerous
TLDR
The chemical, the biotransformation-related, the mechanistic and the therapeutic basis of this clinically relevant and undesirable side effect of drug-induced idiosyncratic agranulocytosis are discussed. Expand
Regional Differences in Prescribing Patterns of Metamizole in Germany Based on Data from 70 Million Persons
TLDR
Prescription prevalence in Germany increased with age, and women received metamizole more often than men, and large regional variations which certainly cannot be explained by patient-related factors were noticed. Expand
A survey of anaesthesia practices at all hospitals performing caesarean sections in Sierra Leone
TLDR
Assessment of the type and training of anaesthesia providers, availability of equipment and drugs and use of perioperative routines in Sierra Leone found that anaesthesia‐related causes of maternal mortality are generally considered preventable. Expand
Agranulozytose nach Metamizol-Einnahme – ein unterschätztes Risiko?
TLDR
Die beschriebenen Patientenfalle zeigen, dass Agranulozytose eine gefahrliche bis teilweise sogar todliche Nebenwirkung nach Metamizol-Einnahme darstellt, die prinzipiell Patienten jeden Alters betreffen kann. Expand
Approaching acute pain in emergency settings; European Society for Emergency Medicine (EUSEM) guidelines—part 2: management and recommendations
TLDR
Treatment recommendations from recently developed guidelines are provided, based on a review of the literature, current practice across Europe and the clinical expertise of the EPI advisors, for both adults and children. Expand
Spezielle Schmerztherapie bei rheumatischen Erkrankungen
TLDR
Dabei wird herausgearbeitet, dass es fur die in diesem Zusammenhang relevantesten Formen des Schmerzes, akut-entzundlich nozizeptiv, neuropathisch and durch periphere and zentrale Sensibilisierung chronifizierte Schmerzen, jeweils andere wirksame Konzepte gibt. Expand
Peripheral nitric oxide signaling directly blocks inflammatory pain.
TLDR
This review summarizes basic concepts of inflammatory pain that are necessary to understand the mechanisms of peripheral NO signaling that promote peripheral analgesia and discusses therapeutic perspectives based on the modulation of the NO pathway. Expand
...
1
2
...

References

SHOWING 1-10 OF 65 REFERENCES
The Incidence of Dipyrone-Induced Agranulocytosis in Greece during 1975
TLDR
A retrospective epidemiological study was conducted in Greece during 1975 to assess the incidence of agranulocytosis following treatment with dipyrone, finding that the incidence lies between one case in every 133,000 and one cases in every 466,000 treatments. Expand
Chronic use of metamizole: not so safe after all?
TLDR
A case of a 68-year-old patient who developed leukopenia after using metamizole is described, which is described as a first case of its kind in the United States. Expand
Metamizole use during first trimester—A prospective observational cohort study on pregnancy outcome
TLDR
The analgesic metamizole (dipyrone) is not recommended during pregnancy due to limited experience, but its use occurs also during pregnancy, often followed by fears of potential teratogenic risk. Expand
Safety of metamizole: a systematic review of the literature
TLDR
A systematic review of the safety of metamizole was performed to quantify the risk of agranulocytosis and other adverse effects associated with metamIZole and other non‐narcotic analgesics. Expand
Agranulocytosis associated with “mexican aspirin” (dipyrone): Evidence for an autoimmune mechanism affecting multipotential hematopoietic progenitors
TLDR
Findings indicate that autoimmune, antibody‐hapten interactions which have been reported to occur in dipyrone‐ and aminopyrine‐induced agranulocytosis are not restricted to the neutrophil lineage. Expand
[Agranulocytosis from metamizole: a potential problem for the British population].
TLDR
Dipyrone-related agranulocytosis is an adverse effect more frequent in British population, and its use must be avoided. Expand
Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990–2012
PurposeIn 1986, the risk of agranulocytosis prompted German authorities to restrict the indications for metamizole use. After an initial decline, prescriptions increased from <20 million definedExpand
Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case–Control Surveillance Study
TLDR
The continuous increase of metamizole applications should be critically assessed, especially in regard to indications in the outpatient setting and with respect to metamzole treatment duration. Expand
Demonstration of drug‐dependent antibodies in two patients with neutrophenia and successful treatment with granulocyte–colony‐stimulating factor
TLDR
This animal study highlights the importance of knowing the carrier and removal status of canine coronavirus, as a source of infection for other animals, not necessarily belonging to the same breeds. Expand
Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole)
TLDR
Based on sales data and spontaneous reporting of adverse drug reactions in Sweden, the risk of agranulocytosis with dipyrone seems to be considerably higher than the previously estimated risks. Expand
...
1
2
3
4
5
...